
BBU Stock Forecast & Price Target
BBU Analyst Ratings
Bulls say
Brookfield Business Partners LP has demonstrated strong financial performance, highlighted by a notable 13% quarter-over-quarter increase in overall EBITDA to $652 million, indicating robust underlying business momentum. Significant contributions came from several segments, including a 29% sequential rise in EBITDA for Scientific Games' lottery service and a 26% sequential increase for Sagen MI Canada's residential mortgage insurance, showcasing the diversity and strength of the company's revenue streams. The favorable market dynamics, such as increased demand for advanced batteries and improved home buyer affordability, further underscore the positive outlook for Brookfield Business Partners in the coming periods.
Bears say
Brookfield Business Partners LP is facing significant financial challenges, as evidenced by a substantial decline in EBITDA for both CDK Global and DexKo, with CDK experiencing a ~36% year-over-year drop and DexKo seeing a ~33% decline in EBITDA. Furthermore, anticipated pressures on underlying investments are projected to result in a compression of EV/EBITDA multiples by 1x across its key segments, including Industrials, Infrastructure Services, and Business Services. Additionally, a forecasted decrease in funds from operations (FFO) and expectations of sell-offs of NAV units throughout 2026 contribute to a negative outlook for the company's financial stability and performance.
This aggregate rating is based on analysts' research of Brookfield Business Partners and is not a guaranteed prediction by Public.com or investment advice.
BBU Analyst Forecast & Price Prediction
Start investing in BBU
Order type
Buy in
Order amount
Est. shares
0 shares